{
  "meta": {
    "title": "32_Inicet_May_2024_Mock_Test-3_Part-4_-_12-05-2024",
    "url": "https://brainandscalpel.vercel.app/32-inicet-may-2024-mock-test-3-part-4-12-05-2024-7b5b3ad2.html",
    "scrapedAt": "2025-11-29T17:23:35.614Z"
  },
  "questions": [
    {
      "id": 43621,
      "choices": [
        {
          "id": 174147,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Normal opening pressure </span></span></span></p>"
        },
        {
          "id": 174148,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Elevated lactate levels </span></span></span></p>"
        },
        {
          "id": 174149,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Presence of eosinophils </span></span></span></p>"
        },
        {
          "id": 174150,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">High adenosine deaminase (ADA) levels</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 5-year-old child presents with symptoms of fever, headache, vomiting, and altered mental status. Cerebrospinal fluid (CSF) analysis reveals lymphocytic pleocytosis, elevated protein levels, and decreased glucose levels. Acid-fast bacilli staining of the CSF is negative, but polymerase chain reaction (PCR) testing detects Mycobacterium tuberculosis DNA. Which of the following additional CSF findings is most likely to support the diagnosis of tubercular meningitis (TBM) in this child?</span></span></p>",
      "unique_key": "Q7079486",
      "question_audio": null,
      "question_video": null,
      "map_id": 5572784,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) High adenosine deaminase (ADA) levels</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tubercular meningitis (TBM) is characterized by a chronic granulomatous inflammation of the meninges caused by Mycobacterium tuberculosis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">While acid-fast bacilli staining of the CSF may be negative in a significant proportion of cases, PCR testing for Mycobacterium tuberculosis DNA provides a more sensitive method for diagnosis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">High levels of adenosine deaminase (ADA) in the CSF (&gt;10 U/L) is a supportive finding in the diagnosis of TBM. ADA is an enzyme involved in the metabolism of purines, and its elevation in the CSF is indicative of a granulomatous process, such as TBM.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Normal opening pressure:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. In TBM, the opening pressure of the CSF is often elevated due to obstruction of CSF flow by inflammatory exudates within the subarachnoid space. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Elevated lactate levels:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. While elevated lactate levels in the CSF may indicate bacterial or viral meningitis, they are not specific to TBM and can be observed in various infectious and inflammatory conditions affecting the central nervous system.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;<strong>Option C. Presence of eosinophils:</strong> Incorrect. The presence of eosinophils in the CSF is suggestive of parasitic or allergic etiologies rather than tubercular meningitis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In suspected cases of tubercular meningitis (TBM), CSF analysis may reveal lymphocytic pleocytosis, elevated protein levels, and decreased glucose levels. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">While acid-fast bacilli staining may be negative, PCR testing for Mycobacterium tuberculosis DNA can aid in diagnosis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Additionally, high levels of adenosine deaminase (ADA) in the CSF (&gt;10 U/L) support the diagnosis of TBM, indicating a granulomatous process.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174150,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43622,
      "choices": [
        {
          "id": 174151,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Flecainide</span></span></span></p>"
        },
        {
          "id": 174152,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tocainide</span></span></span></p>"
        },
        {
          "id": 174153,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propafenone</span></span></p>"
        },
        {
          "id": 174154,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Encainide</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A physician is reviewing the classifications of various anti-arrhythmic drugs to ensure the correct therapeutic choice for a patient with a specific type of cardiac arrhythmia. From the following options, which anti-arrhythmic agent does not belong to class Ic?</span></span></p>",
      "unique_key": "Q9620937",
      "question_audio": null,
      "question_video": null,
      "map_id": 5572785,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">B) Tocainide</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Class Ic anti-arrhythmic drugs are known for their potent effects on blocking sodium channels, which significantly slows the conduction velocity within the heart without altering the action potential duration. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Flecainide, Propafenone, and Encainide all belong to this class, noted for their use in treating severe ventricular arrhythmias and in some cases, atrial fibrillation.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tocainide, on the other hand, belongs to class Ib anti-arrhythmics. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These drugs also block sodium channels but differ in their effects on the action potential; they shorten it. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Class Ib drugs are particularly used for the management of ventricular arrhythmias, especially after myocardial infarction, and are less potent compared to class Ic drugs in terms of slowing conduction velocity.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Flecainide</strong>: Incorrect as an answer to the question because Flecainide is a class Ic anti-arrhythmic agent known for its strong sodium channel blocking capability without affecting the action potential duration.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Propafenone</strong>: Incorrect for exclusion from class Ic. Propafenone shares characteristics similar to Flecainide, including significant effects on conduction velocity in cardiac tissue.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Encainide</strong>: Also incorrect to exclude from class Ic, as Encainide was a well-recognized class Ic drug before its market withdrawal due to safety concerns.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tocainide is not a class Ic anti-arrhythmic agent but belongs to class Ib, which characteristically shortens the action potential and is less potent in slowing conduction compared to class Ic drugs. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This distinction is crucial when choosing the appropriate anti-arrhythmic agent based on the specific cardiac arrhythmias being treated.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43623,
      "choices": [
        {
          "id": 174155,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1 only</span></span></span></p>"
        },
        {
          "id": 174156,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1, 2</span></span></span></p>"
        },
        {
          "id": 174157,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">2, 3</span></span></span></p>"
        },
        {
          "id": 174158,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1, 2, 3, 4</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 34-year-old male presents with recurrent episodes of nausea and vomiting, accompanied by an intense desire for water. Clinical investigations point towards disturbances in fluid and electrolyte balance. Among the listed structures, which are considered circumventricular organs that play a role in monitoring and regulating fluid balance?&nbsp;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1. Area postrema</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">2. Subfornical organ</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">3. Organum Vasculosum of the Lamina Terminalis</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">4. Hypothalamus</span></span></span></p>",
      "unique_key": "Q9895891",
      "question_audio": null,
      "question_video": null,
      "map_id": 5572986,
      "difficulty_level": "difficult",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">C) 2, 3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Circumventricular organs are specialized structures in the brain that interface directly with the blood and cerebrospinal fluid, allowing them to detect and respond to changes in the body&#39;s fluid and electrolyte balance. Among the options given:</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Subfornical organ (2)</span></strong><span style=\"font-size:14.0pt\">: Yes, it plays a direct role in fluid and electrolyte balance by detecting changes in osmolarity and mediating thirst and endocrine responses.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Organum Vasculosum of the Lamina Terminalis (OVLT, 3)</span></strong><span style=\"font-size:14.0pt\">: Yes, it is crucial for detecting osmotic pressure and sodium concentration, influencing the body&#39;s homeostatic mechanisms to manage fluid balance.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options </span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"list-style-type:none\">\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Area postrema (1)</span></strong><span style=\"font-size:14.0pt\">: It is indeed a circumventricular organ but is more traditionally associated with <strong>its role in the vomiting</strong> response to <strong>toxins in the blood</strong>.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Hypothalamus (4)</span></strong><span style=\"font-size:14.0pt\">: While it plays a central role in integrating information and responding to fluid balance, it is not considered a circumventricular organ itself. It receives inputs from circumventricular organs like the OVLT and subfornical organ.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The subfornical organ and the OVLT are key circumventricular organs directly involved in monitoring and regulating fluid and electrolyte balance. </span></span></li>\r\n</ul>",
      "correct_choice_id": 174157,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43624,
      "choices": [
        {
          "id": 174159,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Brain Natriuretic Peptide (BNP) levels </span></span></span></p>"
        },
        {
          "id": 174160,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Right atrial pressure (RAP)</span></span></span></p>"
        },
        {
          "id": 174161,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mean pulmonary artery pressure (mPAP)</span></span></span></p>"
        },
        {
          "id": 174162,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cardiac index (CI)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman with a history of progressive dyspnea and fatigue is diagnosed with pulmonary arterial hypertension after a right heart catheterization. Further evaluation is planned to monitor disease progression and assess her prognosis. Which of the following hemodynamic parameters is least correlated with survival in patients with pulmonary arterial hypertension?</span></span><strong> </strong></p>",
      "unique_key": "Q8626706",
      "question_audio": null,
      "question_video": null,
      "map_id": 5573077,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C) Mean pulmonary artery pressure (mPAP)</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Although mean pulmonary artery pressure (mPAP) is a defining measurement for the diagnosis of pulmonary arterial hypertension (PAH), it is not strongly correlated with survival outcomes in these patients. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Studies have shown that while mPAP indicates the presence of PAH, it does not reliably predict the severity of the disease or the prognosis as other parameters might.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>A. Brain Natriuretic Peptide (BNP) levels</strong>: Elevated BNP levels are correlated with worse outcomes in PAH as they reflect right ventricular strain and heart failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>B. Right atrial pressure (RAP):</strong> Higher RAP is associated with poorer survival in PAH, indicating more severe right heart dysfunction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>D. Cardiac index (CI):</strong> The cardiac index, which measures the cardiac output relative to body size, is a critical indicator of cardiac function and is highly prognostic in PAH, with lower values indicating worse outcomes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">While mean pulmonary artery pressure is essential for diagnosing pulmonary arterial hypertension, it is the least correlated with survival among the parameters listed. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Monitoring of BNP, RAP, and CI provides more valuable prognostic information in managing PAH.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174161,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43625,
      "choices": [
        {
          "id": 174163,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Open inguinal hernia repair: Clean wound</span></span></span></p>"
        },
        {
          "id": 174164,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Incision and drainage of breast abscess: Clean-contaminated wound</span></span></span></p>"
        },
        {
          "id": 174165,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Open cardiac massage: Contaminated wound</span></span></span></p>"
        },
        {
          "id": 174166,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Diabetic wet gangrene: Dirty wound</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the mismatched type of surgical wound:<strong> </strong></span></span></p>",
      "unique_key": "Q9859435",
      "question_audio": null,
      "question_video": null,
      "map_id": 5573118,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Incision and drainage of breast abscess: Clean-contaminated wound</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Option B is mismatched because incision and drainage of a breast abscess typically results in a dirty wound due to the presence of pus. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Therefore, the classification of the wound as clean-contaminated is incorrect.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Open inguinal hernia repair</span></strong><span style=\"font-size:14.0pt\">: <strong>Clean wound</strong> - This is matched correctly as inguinal hernia repair is typically performed under sterile conditions without entering contaminated areas. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Open cardiac massage:</span></strong><span style=\"font-size:14.0pt\"> <strong>Contaminated wound</strong> - This is matched correctly as open cardiac massage involves entry into body cavity with major break in sterility. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Diabetic wet gangrene:</span></strong><span style=\"font-size:14.0pt\"> <strong>Dirty wound</strong> - This is matched correctly as diabetic wet gangrene involves necrotic tissue with an underlying infection, resulting in a dirty wound classification.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-11-135309.JPG\" style=\"height:613px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 174164,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43626,
      "choices": [
        {
          "id": 174167,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Elevated antistreptolysin O titer</span></span></span></p>"
        },
        {
          "id": 174168,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Increased urea nitrogen level</span></span></span></p>"
        },
        {
          "id": 174169,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Positive ANA</span></span></span></p>"
        },
        {
          "id": 174170,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Elevated renin level</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old man has felt progressively fatigued and weak over the past eight months. His temperature is 36.9&deg;C, his pulse rate is 69/min, his respiratory rate is 14/min, and his blood pressure is 160/90 mm Hg. On auscultation, the physician detects a pericardial friction rub. The heart&#39;s gross appearance is displayed in the provided image. Which of the following laboratory findings is most likely to be present in this patient? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-11-133741.JPG\" style=\"height:223px; width:300px\" /></span></span></p>",
      "unique_key": "Q5449461",
      "question_audio": null,
      "question_video": null,
      "map_id": 5573289,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">B) Increased urea nitrogen level</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient&#39;s presentation, including progressive lethargy and weakness, with a pericardial friction rub and the gross image showing fibrinous pericarditis (a &quot;bread and butter&quot; appearance), indicates uremic pericarditis secondary to chronic renal failure. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chronic renal failure leads to an accumulation of urea and nitrogenous waste in the bloodstream, which can provoke an inflammatory response in the pericardium, causing uremic pericarditis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Consequently, laboratory testing will reveal increased blood urea nitrogen levels.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Elevated antistreptolysin O titer:</span></strong><span style=\"font-size:14.0pt\"> Elevated antistreptolysin O (ASO) titer is seen in patients with a history of recent streptococcal infection, commonly associated with rheumatic fever. Rheumatic fever can cause pancarditis, but the presence of a friction rub and the image&#39;s characteristics are more consistent with uremic pericarditis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Positive ANA:</span></strong><span style=\"font-size:14.0pt\"> A positive antinuclear antibody (ANA) test is typically indicative of systemic lupus erythematosus (SLE) or other autoimmune conditions. While SLE can cause pericarditis, this patient&#39;s history and gross heart findings are less suggestive of an autoimmune etiology.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.&nbsp; Elevated renin level:</span></strong><span style=\"font-size:14.0pt\"> Renin levels are elevated in secondary hypertension due to renal artery stenosis or other renal disorders. While chronic renal disease can cause secondary hypertension, an elevated renin level is not directly associated with pericarditis. Instead, elevated urea levels are indicative of renal impairment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Uremic pericarditis is a serious complication of chronic renal failure and is characterized by elevated blood urea nitrogen levels and a pericardial friction rub.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174168,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43627,
      "choices": [
        {
          "id": 174171,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Conventional CPR</span></span></span></p>"
        },
        {
          "id": 174172,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Compression only CPR</span></span></span></p>"
        },
        {
          "id": 174173,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Airway is being secured</span></span></span></p>"
        },
        {
          "id": 174174,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pre-oxygenation in anesthesia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the procedure being performed in this infant:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-11-133759.JPG\" style=\"height:225px; width:300px\" /></span></span></p>",
      "unique_key": "Q6060163",
      "question_audio": null,
      "question_video": null,
      "map_id": 5573330,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Conventional CPR</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Conventional CPR includes chest compressions &amp; rescue breaths as shown in the image.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Compression only CPR:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-11-133816.JPG\" style=\"height:190px; width:300px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Airway is being secured: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-11-133826.JPG\" style=\"height:266px; width:300px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.&nbsp;</span></strong><span style=\"font-size:14.0pt\">Pre-oxygenation in anesthesia: Performed prior to induction to anesthesia and does not involve chest compressions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-11-133840.JPG\" style=\"height:210px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective</span></strong><span style=\"font-size:14.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The choice between conventional CPR, compression-only CPR, securing the airway, and pre-oxygenation in anesthesia are all as given in the above pictures.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174171,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43628,
      "choices": [
        {
          "id": 174175,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Oxygen with NIV</span></span></span></p>"
        },
        {
          "id": 174176,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">CPAP and oxygen</span></span></span></p>"
        },
        {
          "id": 174177,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Invasive mechanical ventilation</span></span></span></p>"
        },
        {
          "id": 174178,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Intravenous salbutamol and morphine</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old man with a history of chronic obstructive pulmonary disease (COPD) (GOLD category E) presents with worsening dyspnea and cough. He is treated with salbutamol nebulizations, intravenous antibiotics, and corticosteroids. His repeat arterial blood gas (ABG) reveals a pH of 7.26, pCO2 of 60 mm Hg, and pO2 of 49.5 mm Hg, with a respiratory rate of 26 breaths per minute. What is the next best step in the management of this patient?</span></span><strong> </strong></p>",
      "unique_key": "Q3073964",
      "question_audio": null,
      "question_video": null,
      "map_id": 5573451,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>A) Oxygen with NIV</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Non-invasive ventilation (NIV), particularly bilevel positive airway pressure (BiPAP), is the next best step for this patient with hypercapnic respiratory failure secondary to a COPD exacerbation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">NIV helps reduce pCO2 by improving alveolar ventilation and reducing the work of breathing. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It has been shown to decrease the need for intubation and improve mortality in appropriately selected patients. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Oxygen should be delivered cautiously to avoid worsening hypercapnia.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. CPAP and oxygen:</span></strong><span style=\"font-size:14.0pt\"> Continuous positive airway pressure (CPAP) is primarily used for obstructive sleep apnea and does not effectively address hypercapnia in COPD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Invasive mechanical ventilation:</span></strong><span style=\"font-size:14.0pt\"> Intubation and invasive mechanical ventilation should be reserved for patients who fail non-invasive ventilation or those with severe respiratory failure or hemodynamic instability.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Intravenous salbutamol and morphine:</span></strong><span style=\"font-size:14.0pt\"> While salbutamol can be used for bronchodilation, morphine is not typically recommended for COPD patients due to its potential for respiratory depression.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Oxygen therapy combined with non-invasive ventilation is the optimal management for COPD patients with hypercapnic respiratory failure to reduce the need for invasive ventilation and improve clinical outcomes.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174175,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43629,
      "choices": [
        {
          "id": 174179,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Gemfibrozil</span></span></span></p>"
        },
        {
          "id": 174180,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Nicotinic acid</span></span></span></p>"
        },
        {
          "id": 174181,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Fenofibrate</span></span></span></p>"
        },
        {
          "id": 174182,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Rosuvastatin</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In reviewing treatment options for a patient with elevated lipoprotein-a [Lp(a)] levels, which of the following lipid-lowering medications is known for significantly reducing Lp(a) levels?</span></span></p>",
      "unique_key": "Q5568842",
      "question_audio": null,
      "question_video": null,
      "map_id": 5573582,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Nicotinic acid</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Nicotinic acid (niacin) is effective in significantly reducing lipoprotein-a [Lp(a)] levels. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lp(a) is a lipoprotein that is structurally similar to LDL, but with an additional protein, apolipoprotein(a), which is linked to an increased risk of cardiovascular diseases such as coronary artery disease and stroke. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Nicotinic acid decreases the production of Lp(a) in the liver and can reduce its plasma concentration by up to 30%. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This effect is unique among lipid-lowering drugs, making niacin particularly useful in patients with elevated Lp(a) levels.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Gemfibrozil</strong>: Incorrect as an answer to this question. Gemfibrozil primarily affects triglyceride levels and has minimal to no significant impact on Lp(a) levels. It is more focused on lowering VLDL particles.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Fenofibrate</strong>: Similar to Gemfibrozil, fenofibrate is primarily effective in reducing triglyceride levels and has limited impact on Lp(a) levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Rosuvastatin</strong>: While statins like rosuvastatin are highly effective in reducing LDL cholesterol, they have minimal effect on Lp(a) levels. In some cases, statins may slightly decrease Lp(a) levels, but this reduction is generally not as significant as that achieved with niacin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Nicotinic acid (niacin) is the lipid-lowering drug that significantly reduces Lp(a) levels, which is important in managing patients at high risk for cardiovascular events due to elevated Lp(a). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This specific action on Lp(a) distinguishes niacin from other classes of lipid-lowering agents.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174180,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43630,
      "choices": [
        {
          "id": 174183,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tegmentum of pons</span></span></span></p>"
        },
        {
          "id": 174184,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Thalamus</span></span></span></p>"
        },
        {
          "id": 174185,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Corpus striatum</span></span></span></p>"
        },
        {
          "id": 174186,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tectum of midbrain</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a discussion on neural pathways, a medical student asks about the transmission of dopamine from the substantia nigra. Which of the following areas receives dopamine via the efferent fiber bundle from the substantia nigra?</span></span></p>",
      "unique_key": "Q3283082",
      "question_audio": null,
      "question_video": null,
      "map_id": 5573623,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C) Corpus striatum</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The substantia nigra, particularly its pars compacta segment, is a major source of dopaminergic neurons. These neurons project primarily to the corpus striatum (part of the basal ganglia) through the nigrostriatal pathway. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This pathway is essential for the modulation of movement, and its impairment is a key factor in Parkinson&#39;s disease, where there is a loss of dopaminergic neurons in the substantia nigra.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Tegmentum of pons:</span></strong><span style=\"font-size:14.0pt\"> The tegmentum of pons does not receive a significant dopaminergic input from the substantia nigra. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Thalamus:</span></strong><span style=\"font-size:14.0pt\"> The thalamus, although a crucial relay station for many neural pathways, does not directly receive dopaminergic fibers from the substantia nigra. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Tectum of midbrain:</span></strong><span style=\"font-size:14.0pt\"> The tectum of the midbrain is involved in visual and auditory reflexes and does not receive direct dopaminergic projections from the substantia nigra.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The role of the substantia nigra&#39;s pars compacta helps in sending dopamine to the corpus striatum via the nigrostriatal pathway, a fundamental neuroanatomical feature crucial for the control of movement and affected in Parkinson&#39;s disease.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174185,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43631,
      "choices": [
        {
          "id": 174187,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">USG abdomen</span></span></span></p>"
        },
        {
          "id": 174188,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">CECT </span><span style=\"font-size:14.0pt\">(Contrast-enhanced computed tomography)</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> abdomen</span></span></span></p>"
        },
        {
          "id": 174189,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">MRCP </span><span style=\"font-size:14.0pt\">(Magnetic Resonance Cholangiopancreatography)</span></span></span></p>"
        },
        {
          "id": 174190,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">ERCP </span><span style=\"font-size:14.0pt\">(Endoscopic Retrograde Cholangiopancreatography)</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old patient came with pain in right hypochondrium. Blood investigation shows AST-22 IU/l and</span></span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ALT-27 IU/ L, serum total bilirubin- 6mg% and ALP-400 mg %. What should be the next investigation in this patient?<strong> </strong></span></span></p>",
      "unique_key": "Q8715207",
      "question_audio": null,
      "question_video": null,
      "map_id": 5573904,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. A) USG abdomen</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient&#39;s presentation with pain in the right hypochondrium and elevated serum total bilirubin and alkaline phosphatase (ALP) levels suggests obstructive biliary pathology. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Given the presence of jaundice, the next investigation of choice is ultrasonography (USG) of the abdomen. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">USG abdomen is a non-invasive imaging modality that can assess the liver, gallbladder, bile ducts, and surrounding structures for abnormalities such as gallstones, biliary obstruction, hepatomegaly, or liver parenchymal changes.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options</span></strong><span style=\"font-size:14.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. CECT abdomen (Contrast-enhanced computed tomography):</span></strong><span style=\"font-size:14.0pt\"> CECT abdomen may provide detailed imaging of the hepatobiliary system and surrounding structures but is generally reserved for cases where USG findings are inconclusive or further characterization of abnormalities is needed. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. MRCP (Magnetic Resonance Cholangiopancreatography):</span></strong><span style=\"font-size:14.0pt\"> MRCP is a non-invasive imaging technique useful for detecting biliary obstruction, bile duct stones, or other biliary pathologies but is typically performed after USG to confirm findings or if USG is inconclusive. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. ERCP (Endoscopic Retrograde Cholangiopancreatography):</span></strong><span style=\"font-size:14.0pt\"> ERCP is an invasive procedure used for both diagnostic and therapeutic purposes in patients with suspected biliary or pancreatic duct pathology. It is generally indicated after non-invasive imaging modalities (such as USG and MRCP) have identified abnormalities requiring intervention.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In a patient presenting with right hypochondrial pain and abnormal liver function tests suggestive of hepatobiliary pathology, the initial investigation of choice is ultrasonography (USG) of the abdomen. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">USG provides valuable information about the liver, gallbladder, and biliary tree and helps guide further management decisions.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174187,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43632,
      "choices": [
        {
          "id": 174191,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chronic lymphadenitis</span></span></span></p>"
        },
        {
          "id": 174192,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;Hodgkin lymphoma</span></span></span></p>"
        },
        {
          "id": 174193,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lymphoblastic lymphoma</span></span></span></p>"
        },
        {
          "id": 174194,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Diffuse large B-cell lymphoma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 56-year-old man presents with a lump near his shoulder. Physical exam reveals an enlarged, non-tender supraclavicular lymph node and enlarged Waldeyer&#39;s ring. The lymph node biopsy shows large lymphoid cells with prominent nucleoli. Immunohistochemistry reveals CD19+, CD10+, CD3-, CD15- and TdT- cells. What is the most likely diagnosis?<strong> </strong></span></span></p>",
      "unique_key": "Q2647573",
      "question_audio": null,
      "question_video": null,
      "map_id": 5573985,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">D) Diffuse large B-cell lymphoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The clinical presentation, combined with immunohistochemical findings (CD19+, CD10+, CD3-, CD15-, TdT-), is consistent with diffuse large B-cell lymphoma (DLBCL). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">DLBCL is an aggressive form of non-Hodgkin lymphoma characterized by rapidly growing lymph nodes and extranodal masses. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The positive markers for CD19 and CD10 indicate a B-cell origin, whereas the absence of TdT rules out lymphoblastic lymphoma. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Additionally, CD3 negativity confirms the lymphoid cells are not T-cell lineage.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-11-133919.JPG\" style=\"height:207px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A.&nbsp; Chronic lymphadenitis:</span></strong><span style=\"font-size:14.0pt\"> Chronic lymphadenitis typically involves generalized lymph node enlargement due to persistent inflammation. The lymph node biopsy findings in this case do not exhibit features of a reactive lymphadenitis, which lacks the monoclonal B-cell population characteristic of lymphoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B.&nbsp; Hodgkin lymphoma:</span></strong><span style=\"font-size:14.0pt\"> Hodgkin lymphoma is typically distinguished by the presence of Reed-Sternberg cells and a characteristic immunophenotype that includes CD15+ and CD30+. However, these markers are absent here, ruling out Hodgkin lymphoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Lymphoblastic lymphoma:</span></strong><span style=\"font-size:14.0pt\"> Lymphoblastic lymphoma is generally positive for terminal deoxynucleotidyl transferase (TdT), a marker of lymphoid progenitor cells. The absence of TdT rules out lymphoblastic lymphoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:14.0pt\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diffuse large B-cell lymphoma (DLBCL) is an aggressive form of non-Hodgkin lymphoma characterized by a population of large lymphoid cells expressing B-cell markers like CD19 and CD10. </span></span></p>",
      "correct_choice_id": 174194,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43633,
      "choices": [
        {
          "id": 174195,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Initiate endotracheal intubation </span></span></span></p>"
        },
        {
          "id": 174196,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Administer intravenous epinephrine </span></span></span></p>"
        },
        {
          "id": 174197,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Perform intraosseous access</span></span></span></p>"
        },
        {
          "id": 174198,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Start therapeutic hypothermia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During neonatal resuscitation, a newborn infant is found to have a heart rate of 50 beats per minute despite adequate ventilation and chest compressions. What is the most appropriate next step in management?</span></span></p>",
      "unique_key": "Q6741623",
      "question_audio": null,
      "question_video": null,
      "map_id": 5574046,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Administer intravenous epinephrine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">When a newborn infant&#39;s heart rate remains below 60 beats per minute despite adequate ventilation and chest compressions during neonatal resuscitation, the most appropriate next step is to administer intravenous epinephrine. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Epinephrine helps to increase myocardial contractility and systemic vascular resistance, thus improving cardiac output and perfusion. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Initiate endotracheal intubation:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. While endotracheal intubation may be considered if effective ventilation cannot be achieved with bag-mask ventilation, the priority in this scenario is to address the persistent bradycardia with intravenous epinephrine. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Perform intraosseous access:</span></strong><span style=\"font-size:14.0pt\"> Incorrect: Intraosseous access may provide vascular access for medication administration or fluid resuscitation but is not the immediate next step in managing persistent bradycardia during neonatal resuscitation. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Start therapeutic hypothermia:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. Therapeutic hypothermia is indicated for newborns with hypoxic-ischemic encephalopathy but is not appropriate as the immediate next step in managing bradycardia during neonatal resuscitation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">During neonatal resuscitation, if a newborn infant&#39;s heart rate remains below 60 beats per minute despite adequate ventilation and chest compressions, the most appropriate next step is to administer intravenous epinephrine to improve cardiac output and perfusion.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174196,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43634,
      "choices": [
        {
          "id": 174199,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Amyloid deposition</span></span></span></p>"
        },
        {
          "id": 174200,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hyperuricemia</span></span></span></p>"
        },
        {
          "id": 174201,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Fanconi syndrome</span></span></span></p>"
        },
        {
          "id": 174202,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hypercalcemia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old man presents with fatigue, bone pain, and recurrent infections. He is diagnosed with multiple myeloma after a bone marrow biopsy shows an excess of plasma cells. Laboratory tests reveal elevated serum creatinine and proteinuria. What is the most common cause of his renal failure?</span></span></p>",
      "unique_key": "Q8479688",
      "question_audio": null,
      "question_video": null,
      "map_id": 5574147,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>D) Hypercalcemia</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In patients with multiple myeloma, hypercalcemia is a common cause of renal failure. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It results from increased bone resorption due to the effects of the disease on bone tissue, leading to elevated levels of calcium in the blood. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This high calcium concentration can lead to kidney damage and impairment of renal function, often presenting with elevated serum creatinine.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>A. Amyloid deposition</strong>: Although amyloid deposition can occur in multiple myeloma, causing organ dysfunction, it is not the most common cause of renal failure in these patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>B. Hyperuricemia</strong>: High uric acid levels can lead to kidney stones and gout but are less frequently the primary cause of renal failure in multiple myeloma compared to hypercalcemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C. Fanconi syndrome</strong>: This is a rare disorder related to kidney tubule function; it is not typically associated with multiple myeloma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hypercalcemia is a significant and common cause of renal failure in patients with multiple myeloma, emphasizing the importance of monitoring and managing calcium levels to prevent renal complications.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43635,
      "choices": [
        {
          "id": 174203,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acetazolamide</span></span></span></p>"
        },
        {
          "id": 174204,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Spironolactone</span></span></span></p>"
        },
        {
          "id": 174205,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Furosemide</span></span></span></p>"
        },
        {
          "id": 174206,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Any of the above</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with cirrhotic ascites is being evaluated for diuretic therapy to manage fluid accumulation. Which of the following diuretics is preferred in the treatment of ascites associated with liver cirrhosis?<strong> </strong></span></span></p>",
      "unique_key": "Q3145382",
      "question_audio": null,
      "question_video": null,
      "map_id": 5574358,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Spironolactone</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Spironolactone is the preferred diuretic for managing cirrhotic ascites. It is a potassium-sparing diuretic that works as an aldosterone antagonist. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In cirrhosis, there is often a hyperaldosteronism condition due to reduced hepatic clearance and portal hypertension, leading to sodium and water retention. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Spironolactone counteracts this by blocking the effects of aldosterone, promoting sodium and water excretion while conserving potassium. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This makes it particularly effective and safer for long-term management of ascites in cirrhotic patients.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Acetazolamide</strong>: This diuretic is not suitable for ascites management in cirrhosis. Acetazolamide is a carbonic anhydrase inhibitor, primarily used to treat conditions like glaucoma, drug-induced edema, and altitude sickness, but it is not effective in the specific management of ascites due to its different mechanism of action, which does not adequately address the pathophysiology of fluid accumulation in cirrhosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C.</strong>&nbsp;<strong>Furosemide</strong>: While furosemide, a loop diuretic, can be used in conjunction with spironolactone in some cases to manage ascites, it is not the first-line treatment due to its potent diuretic effect, which can lead to rapid shifts in fluid and electrolyte balances, potentially worsening the patient&rsquo;s condition if not carefully monitored.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>D. Any of the above</strong>: This option is incorrect because not all diuretics are suitable for the management of cirrhotic ascites. The choice of diuretic should be specific to the pathophysiology involved in cirrhosis, which makes spironolactone the most appropriate choice.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Spironolactone is the diuretic of choice for managing ascites in patients with liver cirrhosis due to its ability to antagonize aldosterone, helping to correct the fluid and electrolyte imbalances typical in this condition.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174204,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43637,
      "choices": [
        {
          "id": 174211,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">No effect by ECF Contraction</span></span></span></p>"
        },
        {
          "id": 174212,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">More Dilute Urine</span></span></span></p>"
        },
        {
          "id": 174213,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Increased Urine Volume, then Decreased</span></span></span></p>"
        },
        {
          "id": 174214,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Concentrated Urine</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 51-year-old individual exhibits symptoms indicating a reduction in extracellular fluid (ECF) volume. The healthcare provider explains the expected renal response to this condition. What change in urine excretion occurs in adults when there is contraction of the extracellular fluid volume?</span></span></p>",
      "unique_key": "Q4398397",
      "question_audio": null,
      "question_video": null,
      "map_id": 5574410,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Concentrated Urine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">In conditions where there is contraction of the extracellular fluid volume, such as dehydration or blood loss, the body&#39;s physiological response is to conserve water to maintain homeostasis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This conservation is facilitated by the increased secretion of antidiuretic hormone (ADH) from the posterior pituitary gland. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">ADH acts on the kidneys to increase water reabsorption in the collecting ducts, resulting in the production of more concentrated urine. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This mechanism effectively minimizes further water loss, helping to stabilize fluid volumes within the body.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A</span></strong><span style=\"font-size:14.0pt\">. <strong>No effect by ECF Contraction</strong>: Incorrect because ECF contraction significantly influences kidney function and ADH secretion, which directly affects urine concentration and volume.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B</span></strong><span style=\"font-size:14.0pt\">. <strong>More Dilute Urine</strong>: Also incorrect. Dilute urine would indicate a lack of ADH effect, which is opposite to the body&#39;s response in ECF contraction scenarios where ADH levels are elevated to conserve water.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C.</span></strong><span style=\"font-size:14.0pt\"> <strong>Increased Urine Volume, later Decreased</strong>: This option is incorrect. Contraction of the ECF typically leads to an immediate and sustained decrease in urine volume, not an initial increase. The body&#39;s priority is to conserve fluid immediately.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">In response to extracellular fluid volume contraction, the body conserves water by producing concentrated urine. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This is mediated by increased levels of antidiuretic hormone, which enhances water reabsorption in the kidneys, a critical adaptive response to prevent further fluid loss.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174214,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43638,
      "choices": [
        {
          "id": 174215,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Diastasis of pubis</span></span></span></p>"
        },
        {
          "id": 174216,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Vesico-ureteric reflux</span></span></span></p>"
        },
        {
          "id": 174217,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Bifid clitoris in female child</span></span></span></p>"
        },
        {
          "id": 174218,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Increased risk of bladder squamous cell CA</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A child is brought to the pediatrician with the condition as shown below. All of these are associated with this condition except?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-11-133945.JPG\" style=\"height:302px; width:300px\" /></span></span></p>",
      "unique_key": "Q9518596",
      "question_audio": null,
      "question_video": null,
      "map_id": 5574641,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Increased risk of bladder squamous cell CA</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The condition shown in the image is of exstrophy of bladder, a congenital malformation involving the lower abdominal wall, bladder, and external genitalia. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">While individuals with exstrophy of bladder are at increased risk of certain complications, such as urinary tract infections and pelvic organ prolapse, there is no documented association with an increased risk of bladder squamous cell carcinoma. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Bladder cancer in these patients is typically of adenocarcinoma type.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Diastasis of pubis:</span></strong><span style=\"font-size:14.0pt\"> Diastasis of the pubic bones is a characteristic feature of exstrophy of bladder, resulting from the failure of fusion of the pubic symphysis during embryonic development. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Vesico-ureteric reflux:</span></strong><span style=\"font-size:14.0pt\"> Vesico-ureteric reflux, where urine flows backward from the bladder into the ureters, is a common finding in individuals with exstrophy of bladder due to the abnormal anatomy and function of the bladder. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Bifid clitoris in female child</span></strong><span style=\"font-size:14.0pt\">: Bifid clitoris, a split in the clitoral structure, can be seen in female children with exstrophy as part of the external genitalia abnormalities associated with the condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Exstrophy of bladder is associated with various congenital anomalies affecting the lower abdominal wall, bladder, and external genitalia. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">While individuals with this condition may experience complications such as urinary tract abnormalities, there is no documented association with an increased risk of bladder squamous cell carcinoma.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174218,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43639,
      "choices": [
        {
          "id": 174219,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Inflammatory fluid is turbid and yellow</span></span></span></p>"
        },
        {
          "id": 174220,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Polymorphonuclear leukocyte predominance</span></span></span></p>"
        },
        {
          "id": 174221,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Presence of stringing effect</span></span></span></p>"
        },
        {
          "id": 174222,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Increased WBC count (2,000&ndash;50,000/&micro;L)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old man with a history of rheumatoid arthritis presents with pain and swelling in his right knee. His physician performs arthrocentesis, and synovial fluid analysis reveals turbid, yellow fluid with elevated white blood cells. Which of the following features would not typically be found in inflammatory synovial fluid?</span></span></p>",
      "unique_key": "Q3885207",
      "question_audio": null,
      "question_video": null,
      "map_id": 5574702,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C) Presence of stringing effect</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Inflammatory synovial fluid generally does not have the &quot;stringing effect,&quot; which is characteristic of normal synovial fluid. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In healthy joints, synovial fluid has high viscosity, resulting in a stringing effect when stretched between the fingers. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In inflammation, the fluid becomes less viscous and loses this property due to increased white blood cells and proteins.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">A. Turbid and yellow fluid:</span></strong><span style=\"font-size:14.0pt\"> Inflammatory synovial fluid is often turbid and yellow due to the presence of immune cells and proteins.</span></span></span></li>\r\n\t<li><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">B. Polymorphonuclear leukocyte predominance:</span></strong><span style=\"font-size:14.0pt\"> Neutrophils (polymorphonuclear leukocytes) are typically the predominant white blood cells in inflammatory fluid.</span></span></span></li>\r\n\t<li><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">D. Increased WBC count (2,000&ndash;50,000/&micro;L):</span></strong><span style=\"font-size:14.0pt\"> This elevated count is consistent with an inflammatory process.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Inflammatory synovial fluid lacks the stringing effect seen in normal fluid because of increased immune cells and proteins, resulting in reduced viscosity.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174221,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43640,
      "choices": [
        {
          "id": 174223,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&alpha;-Antitrypsin</span></span></span></p>"
        },
        {
          "id": 174224,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">CFTR</span></span></span></p>"
        },
        {
          "id": 174225,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">DNA topoisomerase I</span></span></span></p>"
        },
        {
          "id": 174226,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">GM-CSF</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 34-year-old woman presents with a 11-day history of increasing dyspnea and productive cough with gelatinous sputum. She is afebrile, and a chest radiograph shows diffuse bilateral opacification. A transbronchial lung biopsy reveals many lamellar bodies. Antibodies directed against which of the following substances is most likely responsible for her illness?<strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-11-134003.JPG\" style=\"height:199px; width:300px\" /></span></span></p>",
      "unique_key": "Q7329521",
      "question_audio": null,
      "question_video": null,
      "map_id": 5574743,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">D) GM-CSF</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient has pulmonary alveolar proteinosis (PAP), a rare condition characterized by the abnormal accumulation of surfactant in the alveoli, impairing gas exchange. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The acquired form of PAP results from the presence of autoantibodies directed against granulocyte-macrophage colony-stimulating factor (GM-CSF). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This factor is essential for the proper functioning of alveolar macrophages in clearing surfactant from the lungs. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Without effective GM-CSF (Granulocyte-macrophage colony-stimulating factor) activity, surfactant accumulates, leading to symptoms like progressive dyspnea and a productive cough with thick sputum.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acquired PAP can be distinguished from congenital PAP, which is caused by mutations in the GM-CSF gene itself. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Both forms result in impaired surfactant clearance, though the acquired form is due to immune-mediated inhibition. This explains the patient&#39;s significant lung dysfunction, as seen in the biopsy image provided.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. &alpha;-Antitrypsin:</span></strong><span style=\"font-size:14.0pt\"> Deficiency in &alpha;-antitrypsin causes panlobular emphysema due to unregulated protease activity but does not result in the surfactant accumulation characteristic of PAP.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. CFTR:</span></strong><span style=\"font-size:14.0pt\"> Mutations in the CFTR gene cause cystic fibrosis, which leads to thick secretions and widespread bronchiectasis. However, this condition primarily involves a genetic mutation rather than an autoimmune mechanism.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. DNA Topoisomerase I:</span></strong><span style=\"font-size:14.0pt\"> Autoantibodies against DNA topoisomerase I are seen in diffuse scleroderma, resulting in interstitial fibrosis rather than surfactant accumulation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pulmonary alveolar proteinosis (PAP) is an uncommon lung disease caused by impaired surfactant clearance. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In the acquired form, this impairment results from autoantibodies against granulocyte-macrophage colony-stimulating factor (GM-CSF), crucial for the proper functioning of alveolar macrophages.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174226,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43642,
      "choices": [
        {
          "id": 174231,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Normal saline, subcutaneous </span></span></span></p>"
        },
        {
          "id": 174232,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Distilled water, subcutaneous </span></span></span></p>"
        },
        {
          "id": 174233,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">No diluent required, intramuscular </span></span></span></p>"
        },
        {
          "id": 174234,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Thiomersal, intradermal</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A newborn presented in Immunization clinic for MMR vaccination. What is the diluent and route of MMR vaccine according to national immunization schedule?</span></span></p>",
      "unique_key": "Q8727437",
      "question_audio": null,
      "question_video": null,
      "map_id": 5574835,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. B) Distilled water, subcutaneous</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">MMR vaccine </span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Dose: 0.5 ml </span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Route: subcutaneous </span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Site: right upper arm </span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Storage: 2-8 degree Celsius </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The diluent of MMR is distilled water &amp; the diluent of BCG is normal saline.</span></span></span></p>",
      "correct_choice_id": 174232,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43643,
      "choices": [
        {
          "id": 174235,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Triamcinolone</span></span></span></p>"
        },
        {
          "id": 174236,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Dexamethasone</span></span></span></p>"
        },
        {
          "id": 174237,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hydrocortisone</span></span></span></p>"
        },
        {
          "id": 174238,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Betamethasone</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 57-year-old female with adrenal insufficiency is being assessed for appropriate steroid replacement therapy. Given her condition, it is essential to choose a steroid that offers both glucocorticoid and mineralocorticoid activities to mimic natural adrenal function. Which of the following glucocorticoids also exhibits significant mineralocorticoid activity and would be suitable for her treatment?</span></span></p>",
      "unique_key": "Q2454060",
      "question_audio": null,
      "question_video": null,
      "map_id": 5574976,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Hydrocortisone</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hydrocortisone is the steroid that naturally occurs in the body and performs both glucocorticoid and mineralocorticoid functions. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is essential for not only managing inflammation and immune responses but also for maintaining fluid and electrolyte balance through its mineralocorticoid activity. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This makes hydrocortisone particularly suitable for patients with adrenal insufficiency, as it can replace both types of hormones that are deficient.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Triamcinolone</strong>: Incorrect choice for this scenario. Triamcinolone is a synthetic glucocorticoid used primarily for its anti-inflammatory properties and has minimal to no mineralocorticoid activity, making it unsuitable for replacing the mineralocorticoid component in adrenal insufficiency.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Dexamethasone</strong>: Also incorrect. Dexamethasone is a potent glucocorticoid with very high anti-inflammatory efficacy but lacks mineralocorticoid activity, which is necessary for managing electrolyte and fluid balance in adrenal insufficiency.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Betamethasone</strong>: Incorrect as well. Like dexamethasone, betamethasone is a synthetic glucocorticoid that provides excellent anti-inflammatory effects but does not possess the mineralocorticoid activity needed for complete adrenal hormone replacement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hydrocortisone is the appropriate choice for steroid replacement therapy in adrenal insufficiency because it provides both glucocorticoid and mineralocorticoid activities, crucial for mimicking the natural functions of adrenal hormones.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174237,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43644,
      "choices": [
        {
          "id": 174239,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Orad stomach accommodation</span></span></span></p>"
        },
        {
          "id": 174240,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Secondary esophageal peristalsis</span></span></span></p>"
        },
        {
          "id": 174241,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Caudad stomach peristalsis</span></span></span></p>"
        },
        {
          "id": 174242,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Distension-induced intestinal segmentation</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A surgeon is planning a vagotomy for a patient with peptic ulcer disease and discusses the potential impacts on gastrointestinal motor function. Which gastrointestinal motor activity is most likely to be affected by a vagotomy? </span></span></p>",
      "unique_key": "Q4830890",
      "question_audio": null,
      "question_video": null,
      "map_id": 5574997,
      "difficulty_level": "difficult",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>A) Orad stomach accommodation</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vagotomy, which involves cutting the vagus nerve, significantly affects gastric functions that are modulated by vagal innervation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Orad stomach accommodation refers to the stomach&#39;s ability to relax and expand in response to the entry of food, which is mediated by the vagus nerve. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This reflex allows the stomach to increase its volume without a corresponding rise in internal pressure, facilitating the initial stages of digestion.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-11-134046.JPG\" style=\"height:255px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B</span></strong><span style=\"font-size:14.0pt\">. <strong>Secondary esophageal peristalsis:</strong> Secondary esophageal peristalsis is initiated by distension of the esophagus rather than direct vagal control; thus it is less directly affected by a vagotomy. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Caudad stomach peristalsis:</span></strong><span style=\"font-size:14.0pt\"> Caudad stomach peristalsis, which involves the peristaltic movements in the lower stomach responsible for grinding and propelling food into the duodenum, is influenced by the vagus nerve, but the primary impact of vagotomy is more pronounced on gastric accommodation. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Distension-induced intestinal segmentation:</span></strong><span style=\"font-size:14.0pt\"> Distension-induced intestinal segmentation involves the local reflexes within the enteric nervous system for mixing food with digestive juices, and while the vagus nerve can modulate this activity, it is not as directly impacted by vagotomy as gastric accommodation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The critical takeaway is that orad stomach accommodation, which heavily relies on vagal innervation, is significantly affected by vagotomy. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This knowledge is important when considering the effects of surgical interventions on gastrointestinal function, particularly in patients with peptic ulcer disease.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174239,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43645,
      "choices": [
        {
          "id": 174243,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">High blood pressure</span></span></span></p>"
        },
        {
          "id": 174244,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Abnormal audiometry</span></span></span></p>"
        },
        {
          "id": 174245,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hepatomegaly</span></span></span></p>"
        },
        {
          "id": 174246,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Crystalline corneal deposits </span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A newborn is brought for an examination by her parents because of concerns about growth and unusual symptoms. The pediatrician suspects cystinosis, a rare genetic disorder. Which of the following findings would support this diagnosis?</span></span></p>",
      "unique_key": "Q3392993",
      "question_audio": null,
      "question_video": null,
      "map_id": 5575078,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>D) Crystalline corneal deposits</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cystinosis is a genetic disorder caused by mutations in the <em>CTNS</em> gene, leading to defective transport of cystine out of cellular lysosomes. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">As a result, cystine accumulates and forms crystals in various tissues. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Crystalline corneal deposits are a hallmark of cystinosis and are often present in the cornea of affected individuals, sometimes causing photophobia.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. High blood pressure:</span></strong><span style=\"font-size:14.0pt\"> While high blood pressure can occur in other kidney disorders, it&#39;s not specifically linked to cystinosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Abnormal audiometry:</span></strong><span style=\"font-size:14.0pt\"> Hearing abnormalities are not a common finding in cystinosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Hepatomegaly:</span></strong><span style=\"font-size:14.0pt\"> This is not a typical feature of cystinosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Crystalline corneal deposits are characteristic of cystinosis and can help differentiate this condition from other inherited metabolic disorders.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174246,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43646,
      "choices": [
        {
          "id": 174247,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">1B: Diffuse ooze</span></span></span></p>"
        },
        {
          "id": 174248,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">2A: Visible vessel</span></span></span></p>"
        },
        {
          "id": 174249,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">2B: Adherent clot</span></span></span></p>"
        },
        {
          "id": 174250,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">2C: Clean-based ulcer</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the mismatch in Forrest&#39;s grades of peptic ulcer bleeding: </span></span></p>",
      "unique_key": "Q6436122",
      "question_audio": null,
      "question_video": null,
      "map_id": 5575159,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) 2C: Clean based ulcer</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Forrest&#39;s classification is a system used to classify peptic ulcer bleeding based on endoscopic findings. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The mismatch in this classification is option D, 2C: Clean based ulcer.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In Forrest&#39;s classification:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-11-134110.JPG\" style=\"height:541px; width:733px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Therefore, option D, 2C: Clean based ulcer, is mismatched. Grade 2C refers to a flat pigmented spot/acid dot.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A. 1B:</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Diffuse ooze</strong> - This matches correctly with Forrest&#39;s classification</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B. 2A:</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Visible vessel</strong> - This matches correctly with Forrest&#39;s classification</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option C. 2B:</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Adherent clot</strong> - This matches correctly with Forrest&#39;s classification</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Forrest&#39;s classification is a useful tool for stratifying the risk of rebleeding in peptic ulcer bleeding based on endoscopic findings. </span></span></li>\r\n</ul>",
      "correct_choice_id": 174250,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43647,
      "choices": [
        {
          "id": 174251,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">G-CSF</span></span></span></p>"
        },
        {
          "id": 174252,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Erythropoietin analogue</span></span></span></p>"
        },
        {
          "id": 174253,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">GM-CSF</span></span></span></p>"
        },
        {
          "id": 174254,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">IL-11 analogue</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During a treatment planning session for a patient who has recently undergone a bone marrow transplant, the medical team considers the use of a growth factor to aid in the recovery of the patient&#39;s immune system. Which of the following growth factors is Sargramostim?</span></span></p>",
      "unique_key": "Q3780871",
      "question_audio": null,
      "question_video": null,
      "map_id": 5575160,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) GM-CSF</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sargramostim is a recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is primarily used to promote bone marrow recovery after bone marrow transplantation, during chemotherapy, and in some cases after radiation therapy. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">GM-CSF acts by stimulating the differentiation and proliferation of precursor cells into granulocytes and macrophages, thereby enhancing the immune function and reducing the incidence of infection in immunocompromised patients.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Erythropoietin analogue</strong>: Incorrect. Erythropoietin analogues, such as epoetin alfa, are used primarily to treat anemia, specifically by stimulating the production of red blood cells in the bone marrow, not granulocytes or macrophages.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><strong>IL-11 analogue</strong>: Also incorrect. </span><span style=\"font-size:14.0pt\">IL-11 analogues, like oprelvekin, are used to increase platelet production in patients undergoing chemotherapy, which is different from the effects of GM-CSF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>G-CSF</strong>: Incorrect for Sargramostim. G-CSF (granulocyte colony-stimulating factor), such as filgrastim, specifically stimulates the production of neutrophils, which is narrower in scope compared to GM-CSF&rsquo;s action on both granulocytes and macrophages.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sargramostim is a GM-CSF, used for stimulating the growth of both granulocytes and macrophages in the bone marrow, which helps improve immune function and reduce the risk of infections in patients with compromised bone marrow function, such as those undergoing chemotherapy or bone marrow transplantation.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174253,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43648,
      "choices": [
        {
          "id": 174255,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Protein complexed to U1 RNA</span></span></span></p>"
        },
        {
          "id": 174256,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Protein in ribosomes</span></span></span></p>"
        },
        {
          "id": 174257,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Protein complexed to hY RNA</span></span></span></p>"
        },
        {
          "id": 174258,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Neuronal and lymphocyte surface antigens</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old woman presents with fatigue, joint pain, and a malar rash. Her laboratory tests reveal a positive antinuclear antibody (ANA) test and anemia. She undergoes further testing, which shows the presence of anti-Sm antibodies. These antibodies are most likely directed against which of the following structures?</span></span><strong> </strong></p>",
      "unique_key": "Q6535538",
      "question_audio": null,
      "question_video": null,
      "map_id": 5575201,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>A) Protein complexed to U1 RNA</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Anti-Sm antibodies target small nuclear ribonucleoproteins (snRNPs), specifically U1 snRNP, which is composed of proteins complexed to U1 RNA. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These snRNPs are involved in the splicing of pre-mRNA to mature mRNA. Anti-Sm antibodies are highly specific for systemic lupus erythematosus (SLE), helping confirm the diagnosis.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Protein in ribosomes:</span></strong><span style=\"font-size:14.0pt\"> Ribosomal proteins are not the specific target of anti-Sm antibodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Protein complexed to hY RNA:</span></strong><span style=\"font-size:14.0pt\"> This description matches the Ro/SSA antigen, which is associated with Sjogren&#39;s syndrome and some cases of SLE, but not anti-Sm.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Neuronal and lymphocyte surface antigens:</span></strong><span style=\"font-size:14.0pt\"> These antigens are not associated with anti-Sm antibodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Anti-Sm antibodies are specific markers for SLE and target proteins associated with U1 RNA, forming a crucial part of the spliceosome machinery.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174255,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43649,
      "choices": [
        {
          "id": 174259,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Interstitial fibrosis</span></span></span></p>"
        },
        {
          "id": 174260,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lymphocytic infiltrates</span></span></span></p>"
        },
        {
          "id": 174261,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Alveolar hyaline membranes</span></span></span></p>"
        },
        {
          "id": 174262,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Arterial plexiform lesions</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old woman with postpartum sepsis has worsening oxygenation and scattered bilateral pulmonary opacifications on chest X-ray. Ventilation-perfusion scanning shows mismatched areas. This condition is related to increased release of nuclear factor Kappa-B, interleukin-8, and tumor necrosis factor, which damage the endothelium and type I cells. Which microscopic finding is most likely present in her lungs?</span></span></p>",
      "unique_key": "Q8066344",
      "question_audio": null,
      "question_video": null,
      "map_id": 5575222,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">C) Alveolar hyaline membranes</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Alveolar hyaline membranes consist of fibrin and necrotic epithelial cells and are a hallmark feature of diffuse alveolar damage (DAD). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This condition underlies acute respiratory distress syndrome (ARDS), which often develops in patients with sepsis, like this woman. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The scattered bilateral opacifications and ventilation-perfusion mismatch suggest significant alveolar-capillary damage, consistent with ARDS and DAD. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The inflammatory response to sepsis triggers cytokine release and increased vascular permeability, leading to exudation into the alveoli, culminating in the formation of hyaline membranes.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-11-134135.JPG\" style=\"height:167px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Interstitial Fibrosis:</strong> Interstitial fibrosis is characteristic of chronic interstitial lung diseases like idiopathic pulmonary fibrosis (IPF). These conditions are associated with persistent inflammation and remodeling, causing fibrotic scarring in the lung parenchyma. They are not typically observed in acute conditions like ARDS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Lymphocytic Infiltrates:</strong> Lymphocytic infiltrates may be seen in various chronic conditions involving immune activation or infection. Although lymphocytes can contribute to pulmonary inflammation, their presence is not the primary feature of diffuse alveolar damage or ARDS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Arterial Plexiform Lesions:</strong> Arterial plexiform lesions are indicative of pulmonary arterial hypertension (PAH) and result from remodeling of small pulmonary arteries. They are not associated with ARDS or diffuse alveolar damage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Alveolar hyaline membranes are a pathologic hallmark of diffuse alveolar damage (DAD) and are most commonly seen in acute respiratory distress syndrome (ARDS), often triggered by conditions like sepsis.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174261,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43650,
      "choices": [
        {
          "id": 174263,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">1-a, 2-b, 3-c, 4-d</span></span></span></p>"
        },
        {
          "id": 174264,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">1-c, 2-b, 3-a,4-d</span></span></span></p>"
        },
        {
          "id": 174265,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">1-c, 2-a, 3-b, 4-d</span></span></span></p>"
        },
        {
          "id": 174266,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">1-b, 2-c, 3-a, 4-d</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following milestones with age when it is achieved:</span></span><strong> </strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-11-144725.JPG\" style=\"height:244px; width:700px\" /></p>",
      "unique_key": "Q9044001",
      "question_audio": null,
      "question_video": null,
      "map_id": 5575283,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. C) 1-c, 2-a, 3-b, 4-d</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sits in tripod position is typically achieved at 6 months of age (option c).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mature pincer grasp is typically achieved at 12 months of age (option a).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Runs is typically achieved at 18 months of age (option b).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Makes 2-3 word sentences are typically achieved at 2 years of age (option d).</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sits in tripod position - c) 6 months</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mature pincer grasp - a) 12 months</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Runs - b) 18 months</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Makes 2-3 word sentences - d) 2 years</span></span></span></li>\r\n</ol>",
      "correct_choice_id": 174265,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43651,
      "choices": [
        {
          "id": 174267,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Nasal chondritis</span></span></span></p>"
        },
        {
          "id": 174268,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Auricular chondritis</span></span></span></p>"
        },
        {
          "id": 174269,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Saddle nose deformity</span></span></span></p>"
        },
        {
          "id": 174270,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Elevated creatinine</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the most frequent presenting manifestation of relapsing polychondritis?</span></span></p>",
      "unique_key": "Q3463764",
      "question_audio": null,
      "question_video": null,
      "map_id": 5575344,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>B) Auricular chondritis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Auricular chondritis is the most common initial manifestation of relapsing polychondritis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Patients typically present with inflammation, swelling, and tenderness of the cartilaginous portions of the external ear, while the ear lobes are spared. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Over time, repeated episodes of chondritis can lead to cartilage destruction and deformity.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Nasal chondritis:</span></strong><span style=\"font-size:14.0pt\"> Although nasal chondritis is common in relapsing polychondritis, it typically occurs later and is less frequent as the initial manifestation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Saddle nose deformity:</span></strong><span style=\"font-size:14.0pt\"> This is a late finding resulting from chronic cartilage destruction and often follows repeated episodes of nasal chondritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Elevated creatinine:</span></strong><span style=\"font-size:14.0pt\"> Elevated creatinine is not directly linked to relapsing polychondritis but could occur if renal involvement is present.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Auricular chondritis is the most frequent presenting feature of relapsing polychondritis, with symptoms often sparing the ear lobes.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174268,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43654,
      "choices": [
        {
          "id": 174279,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Germline transmission of a defective RB gene</span></span></span></p>"
        },
        {
          "id": 174280,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Amplification of ERBB2 gene</span></span></span></p>"
        },
        {
          "id": 174281,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A defective DNA mismatch-repair gene</span></span></span></p>"
        },
        {
          "id": 174282,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Overexpression of E-cadherin gene</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old man undergoes a health examination where a stool sample is positive for occult blood. A colonoscopy identifies an ulcerating mass in the cecum. The microscopic appearance of the excised lesion reveals characteristic histopathological features. Which of the following molecular abnormalities is most critical in the development of this lesion?<strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-11-134245.JPG\" style=\"height:233px; width:300px\" /></p>",
      "unique_key": "Q2088587",
      "question_audio": null,
      "question_video": null,
      "map_id": 5575477,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">C) A defective DNA mismatch-repair gene</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The defective DNA mismatch-repair gene pathway is most critical for the development of colorectal cancer, particularly in individuals with Lynch syndrome (hereditary nonpolyposis colorectal cancer, HNPCC). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In Lynch syndrome, mutations in DNA mismatch-repair genes such as MLH1 and MSH2 lead to the inability to correct replication errors, resulting in the accumulation of genetic mutations. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This accumulation manifests microscopically as the architectural distortion observed in the biopsy image. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lynch syndrome has a strong association with early-onset colorectal cancer, particularly involving right-sided (cecal) tumors.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Germline transmission of a defective RB gene:</span></strong><span style=\"font-size:14.0pt\"> Defective RB genes are more closely associated with hereditary retinoblastoma and osteosarcoma. They do not primarily cause colorectal tumors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Amplification of ERBB2 gene:</span></strong><span style=\"font-size:14.0pt\"> ERBB2 (HER2/neu) gene amplification is implicated in certain breast and gastric cancers but is not a primary driver of colorectal cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Overexpression of E-cadherin gene:</span></strong><span style=\"font-size:14.0pt\"> E-cadherin overexpression is typically associated with gastric cancer and plays a lesser role in colorectal cancer pathogenesis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lynch syndrome results from inherited mutations in DNA mismatch-repair genes, leading to an increased risk of colorectal cancer, usually presenting with early-onset right-sided tumors in the cecum or ascending colon.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174281,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43655,
      "choices": [
        {
          "id": 174283,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Alogliptin</span></span></span></p>"
        },
        {
          "id": 174284,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Linagliptin</span></span></span></p>"
        },
        {
          "id": 174285,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sitagliptin</span></span></span></p>"
        },
        {
          "id": 174286,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vildagliptin</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which DPP-4 inhibitor used in the treatment of diabetes mellitus requires dose adjustments in patients with both liver and renal disease?</span></span></p>",
      "unique_key": "Q9401485",
      "question_audio": null,
      "question_video": null,
      "map_id": 5575498,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Vildagliptin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that requires dose adjustments in patients with both liver and renal impairments. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vildagliptin is metabolized in the liver and excreted by the kidneys, making dose adjustments necessary to avoid accumulation and potential toxicity in patients with impaired liver or kidney function. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This careful management helps maintain drug efficacy while minimizing the risk of adverse effects due to altered pharmacokinetics in these patients.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Alogliptin:</span></strong><span style=\"font-size:14.0pt\"> Requires dose adjustments primarily in renal impairment, not typically in liver disease, as its metabolism and excretion are significantly affected by kidney function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Linagliptin</strong>: This DPP-4 inhibitor does not usually require dose adjustments in renal or liver disease due to its unique pharmacokinetic profile, including minimal renal excretion and extensive non-renal elimination.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Sitagliptin</strong>: Primarily requires dose adjustment in cases of renal impairment. Liver disease does not significantly impact the dosing of sitagliptin, as its pharmacokinetics are chiefly influenced by renal function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vildagliptin requires dose adjustments in both liver and renal disease among the DPP-4 inhibitors, distinguishing it from other agents in its class that might only need adjustments for renal impairment. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This requirement underscores the importance of considering both organ functions when prescribing this medication.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174286,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43658,
      "choices": [
        {
          "id": 174295,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Paul Miculicz Procedure</span></span></span></p>"
        },
        {
          "id": 174296,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Bishop-Koop Procedure</span></span></span></p>"
        },
        {
          "id": 174297,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Hartmann Procedure</span></span></span></p>"
        },
        {
          "id": 174298,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Anterior Resection</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The procedure done below, for strangulated sigmoid volvulus, is termed as:<strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-11-134302.JPG\" style=\"height:341px; width:300px\" /></strong></span></span></p>",
      "unique_key": "Q1995698",
      "question_audio": null,
      "question_video": null,
      "map_id": 5575561,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Paul Miculicz Procedure</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The procedure described for the management of strangulated sigmoid volvulus, involving resection of the sigmoid colon and creation of a double-barrel stoma, is known as the Paul Miculicz procedure. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This surgical intervention aims to relieve the obstruction and prevent recurrence of sigmoid volvulus by resecting the twisted segment of the colon and creating an ostomy.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Bishop-Koop procedure:</span></strong><span style=\"font-size:14.0pt\"> This procedure is performed for the management of meconium ileus, a condition seen in infants with cystic fibrosis, and involves enterostomy or ileostomy creation. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Hartmann procedure:</span></strong><span style=\"font-size:14.0pt\"> The Hartmann procedure involves resection of the diseased segment of the colon, closure of the rectal stump, and creation of an end colostomy. It is commonly performed for emergent management of colorectal emergencies such as perforated diverticulitis or obstructing colorectal cancer with significant comorbidities precluding primary anastomosis. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Anterior resection:</span></strong><span style=\"font-size:14.0pt\"> Anterior resection is a surgical procedure performed for rectal cancers located in the upper or middle rectum. It involves removal of the tumor along with a segment of the rectum and mesorectum, followed by anastomosis of the remaining bowel segments.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Paul Miculicz procedure is a surgical intervention utilized for the management of strangulated sigmoid volvulus, involving resection of the twisted sigmoid colon and creation of a double-barrel stoma to relieve the obstruction and prevent recurrence. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174295,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43659,
      "choices": [
        {
          "id": 174299,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Enterobius vermicularis</span></span></span></p>"
        },
        {
          "id": 174300,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Strongyloides stercoralis</span></span></span></p>"
        },
        {
          "id": 174301,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ankylostoma caninum</span></span></span></p>"
        },
        {
          "id": 174302,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Capillaria philippinensis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 56-year-old man who is on chronic steroid therapy develops symptoms of respiratory difficulty and hypotension. A bronchoalveolar lavage (BAL) is performed, revealing larvae. What is the most likely parasite responsible for this patient&#39;s condition?</span></span></p>",
      "unique_key": "Q9866952",
      "question_audio": null,
      "question_video": null,
      "map_id": 5575672,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>B) Strongyloides stercoralis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Strongyloides stercoralis is a parasitic nematode that can cause hyperinfection syndrome, especially in immunocompromised individuals, including those on chronic steroid therapy. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The parasite&#39;s larvae can penetrate through the gastrointestinal tract or skin and disseminate through the bloodstream, causing severe respiratory and gastrointestinal symptoms.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Enterobius vermicularis:</span></strong><span style=\"font-size:14.0pt\"> This parasite causes enterobiasis (pinworm infection), which typically manifests as perianal itching rather than systemic symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Ankylostoma caninum:</span></strong><span style=\"font-size:14.0pt\"> This hookworm mainly infects dogs and may cause cutaneous larva migrans in humans but doesn&#39;t cause a hyperinfection syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Capillaria philippinensis:</span></strong><span style=\"font-size:14.0pt\"> This intestinal parasite causes capillariasis, primarily affecting Southeast Asia, and doesn&#39;t result in disseminated infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Strongyloides stercoralis can cause severe hyperinfection syndrome in immunocompromised patients, making early diagnosis and treatment crucial.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174300,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43661,
      "choices": [
        {
          "id": 174307,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Non-Hodgkin lymphoma</span></span></span></p>"
        },
        {
          "id": 174308,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Adenocarcinoma</span></span></span></p>"
        },
        {
          "id": 174309,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Gastric mucosa</span></span></span></p>"
        },
        {
          "id": 174310,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pancreatic acini</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 17-year-old boy undergoes exploratory surgery after suffering a penetrating abdominal trauma. A tan, solid, circumscribed mass, 1.5 cm in diameter, is found within the jejunal wall. After resecting the perforated segment, the mass is sent for frozen section analysis. Which of the following histologic structures would pathologist most likely to identify under the microscope?</span></span></p>",
      "unique_key": "Q8959890",
      "question_audio": null,
      "question_video": null,
      "map_id": 5575754,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><span style=\"font-size:14.0pt\">&nbsp;<strong>D) Pancreatic acini</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The solid, circumscribed, tan mass identified in the jejunal submucosa represents an <strong>ectopic (heterotopic) pancreas</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This condition occurs when pancreatic acini and ducts are located outside of the pancreas, often in the stomach or small intestine. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The microscopic examination typically reveals pancreatic acini with ductal structures, reflecting the characteristic architecture of pancreatic tissue. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Heterotopic pancreatic tissue is usually asymptomatic but can lead to complications like bleeding, inflammation, or obstruction.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Non-Hodgkin lymphoma:</span></strong><span style=\"font-size:14.0pt\"> Non-Hodgkin lymphoma would present as diffuse lymphocytic infiltration, not acinar-like structures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Adenocarcinoma:</span></strong><span style=\"font-size:14.0pt\"> Adenocarcinoma forms glandular structures rather than the distinctive pancreatic acini.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Gastric mucosa:</span></strong><span style=\"font-size:14.0pt\"> Gastric mucosa has distinctive rugae and different architecture that is specific to the stomach.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ectopic pancreas (heterotopic pancreas) refers to pancreatic tissue found outside of its usual location, often in the stomach or small intestine. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It can be asymptomatic or cause complications like obstruction or inflammation. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174310,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43663,
      "choices": [
        {
          "id": 174315,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Entacapone</span></span></span></p>"
        },
        {
          "id": 174316,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Ropinirole</span></span></span></p>"
        },
        {
          "id": 174317,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Levodopa</span></span></span></p>"
        },
        {
          "id": 174318,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Bromocriptine</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A neurologist is reviewing treatment plans for Parkinson&#39;s disease to ensure awareness of potential side effects, particularly concerning blood flow to the extremities. Which anti-Parkinsonian medication is recognized for causing peripheral vasospasm?<strong> </strong></span></span></p>",
      "unique_key": "Q2166800",
      "question_audio": null,
      "question_video": null,
      "map_id": 5575826,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">D) Bromocriptine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Bromocriptine, a dopamine agonist that is part of the ergot alkaloid class, is associated with peripheral vasospasm. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This side effect arises from its ergot structure, which can cause constriction of blood vessels. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Peripheral vasospasm can lead to symptoms such as cold fingers and toes, numbness, and pain in the extremities due to reduced blood flow. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This is a significant consideration when prescribing this medication, particularly in patients with pre-existing circulatory problems.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Entacapone</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Entacapone is a COMT inhibitor used to extend the effect of levodopa by preventing its breakdown. It is not associated with peripheral vasospasm as a side effect.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Ropinirole</strong>: Also incorrect. Ropinirole is a non-ergot dopamine agonist, primarily associated with side effects such as nausea, dizziness, and somnolence, but not peripheral vasospasm.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Levodopa</strong>: Incorrect. Levodopa, often combined with carbidopa, is the most effective and commonly used medication for Parkinson&#39;s disease but does not typically cause peripheral vasospasm. Its side effects are more commonly related to motor fluctuations and dyskinesias.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Bromocriptine, an ergot-derived dopamine agonist, can cause peripheral vasospasm as a side effect, which is an important consideration in the treatment plan for Parkinson&rsquo;s disease patients, especially those with existing circulatory issues.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174318,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43665,
      "choices": [
        {
          "id": 174323,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">EVAR (Endovascular Aneurysm Repair)</span></span></span></p>"
        },
        {
          "id": 174324,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">USG monitoring till the size of the aneurysm reaches 70 mm</span></span></span></p>"
        },
        {
          "id": 174325,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Elective surgery after size reaches 55 mm</span></span></span></p>"
        },
        {
          "id": 174326,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Conservative management</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A&nbsp;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">75 y / male patient with hypertension presents to the hospital with severe abdominal pain and is detected with an abdominal aortic aneurysm of size 50 mm. What is the appropriate management of this patient?</span></span><strong> </strong></p>",
      "unique_key": "Q5439725",
      "question_audio": null,
      "question_video": null,
      "map_id": 5575848,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Ans. A) EVAR (Endovascular Aneurysm Repair)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In a 75-year-old male patient with hypertension presenting with severe abdominal pain and a detected abdominal aortic aneurysm (AAA) of size 50 mm, the appropriate management is Endovascular Aneurysm Repair (EVAR). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">EVAR is a minimally invasive procedure performed to repair abdominal aortic aneurysms by placing a stent graft within the aneurysm to reinforce the weakened vessel wall and prevent rupture.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Key considerations for selecting EVAR in this patient include symptomatic presentation with severe abdominal pain (suggestive of impending rupture), and the patient&#39;s age and comorbidities. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">EVAR is the preferred treatment option for AAA in many cases, particularly for patients with smaller aneurysm sizes, older age, and significant comorbidities, as it is associated with lower perioperative morbidity and mortality compared to open surgical repair.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. USG monitoring till the size of the aneurysm reaches 70 mm:</span></strong><span style=\"font-size:14.0pt\"> This approach is not appropriate in this scenario as the patient presents with severe abdominal pain, indicating a symptomatic AAA, which requires immediate intervention to prevent rupture. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Elective surgery after size reaches 55 mm:</span></strong><span style=\"font-size:14.0pt\"> Waiting for the aneurysm to reach 55 mm before considering elective surgery is not advisable, especially given the patient&#39;s symptomatic presentation and the current size of the aneurysm at 50 mm, which exceeds the threshold for intervention. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Conservative management:</span></strong><span style=\"font-size:14.0pt\"> Conservative management without intervention is not appropriate in this scenario due to the high risk of rupture associated with the size of the aneurysm and the patient&#39;s symptomatic presentation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In a patient with a symptomatic abdominal aortic aneurysm measuring 50 mm, Endovascular Aneurysm Repair (EVAR) is the appropriate management to prevent rupture and associated complications. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174323,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43667,
      "choices": [
        {
          "id": 174331,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">IgG</span></span></span></p>"
        },
        {
          "id": 174332,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">IgA</span></span></span></p>"
        },
        {
          "id": 174333,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">IgM</span></span></span></p>"
        },
        {
          "id": 174334,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">IgD</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old man with a history of heavy alcohol consumption presents with jaundice, fatigue, and right upper quadrant pain. His liver function tests show elevated liver enzymes and bilirubin. Additional blood tests reveal elevated levels of a particular immunoglobulin. Which of the following immunoglobulins is most commonly increased in patients with alcoholic liver disease?</span></span></p>",
      "unique_key": "Q5604134",
      "question_audio": null,
      "question_video": null,
      "map_id": 5575890,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>B) IgA</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In alcoholic liver disease, chronic alcohol exposure causes immune alterations, leading to elevated serum IgA levels. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This increase is due to mucosal immune activation. IgA predominantly functions in mucosal immunity, and its elevation in alcoholic liver disease contributes to hepatic inflammation and fibrosis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is a distinctive finding in this condition, unlike other types of liver disease.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. IgG:</span></strong><span style=\"font-size:14.0pt\"> Although elevated in various autoimmune liver diseases (e.g., autoimmune hepatitis), it is not specifically linked to alcoholic liver disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. IgM:</span></strong><span style=\"font-size:14.0pt\"> High IgM levels are more indicative of autoimmune liver conditions like primary biliary cholangitis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. IgD:</span></strong><span style=\"font-size:14.0pt\"> This immunoglobulin is not specifically associated with alcoholic liver disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Elevated IgA levels are characteristic of alcoholic liver disease due to immune activation from chronic alcohol exposure.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174332,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43669,
      "choices": [
        {
          "id": 174339,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hydrocephalus</span></span></span></p>"
        },
        {
          "id": 174340,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Laminar cortical necrosis</span></span></span></p>"
        },
        {
          "id": 174341,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Uncal herniation</span></span></span></p>"
        },
        {
          "id": 174342,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Subarachnoid hemorrhage</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old man presents with a severe headache and fever lasting two days. He shows nuchal rigidity on examination, and his temperature is 38.5&deg;C. A lumbar puncture reveals gram-positive cocci in chains, with <em>Streptococcus pneumoniae</em> cultured. Despite antibiotic therapy, the patient dies. The autopsy image shows a section of the brain. Based on this appearance, which of the following complications most likely resulted from this infection?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-11-134402.JPG\" style=\"height:301px; width:300px\" /></span></span></p>",
      "unique_key": "Q2242247",
      "question_audio": null,
      "question_video": null,
      "map_id": 5576012,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">Uncal herniation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In this case, acute bacterial meningitis resulted in significant cerebral edema, ultimately leading to uncal herniation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This herniation placed excessive pressure on the brainstem, causing linear midline hemorrhages in the pons known as <strong>Duret hemorrhages</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The infection can also result in scarring of the arachnoid granulations or foramina, disrupting cerebrospinal fluid (CSF) flow and potentially leading to hydrocephalus.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Although an abscess may occasionally complicate meningitis or trigger it by extending from the paranasal sinuses or mastoid air cells, this complication is not seen in the provided image. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Laminar cortical necrosis might occur post-mortem due to prolonged ischemia but is not specific to meningitis.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Hydrocephalus:</span></strong><span style=\"font-size:14.0pt\"> While meningitis can cause communicating hydrocephalus through scarring, the patient died due to raised intracranial pressure leading to herniation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Laminar cortical necrosis:</span></strong><span style=\"font-size:14.0pt\"> This refers to selective neuronal death, often from prolonged cerebral ischemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Subarachnoid hemorrhage:</span></strong><span style=\"font-size:14.0pt\"> Involves bleeding into the subarachnoid space, unrelated to the findings associated with meningitis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acute bacterial meningitis can result in brain edema and herniation, leading to brainstem compression and midline hemorrhages known as Duret hemorrhages.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174341,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43671,
      "choices": [
        {
          "id": 174347,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Phenytoin</span></span></span></p>"
        },
        {
          "id": 174348,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lamotrigine</span></span></span></p>"
        },
        {
          "id": 174349,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vigabatrin</span></span></span></p>"
        },
        {
          "id": 174350,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Valproate</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pharmacology resident is reviewing the mechanisms of action for various antiepileptic drugs to optimize treatment choices based on their pharmacological profiles. Which of the following antiepileptic agents does not act primarily through sodium channel modulation?<strong> </strong></span></span></p>",
      "unique_key": "Q2611818",
      "question_audio": null,
      "question_video": null,
      "map_id": 5576264,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Vigabatrin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vigabatrin is an antiepileptic drug that does not act via sodium channel modulation. Instead, its primary mechanism of action is the irreversible inhibition of gamma-aminobutyric acid transaminase (GABA-T), the enzyme responsible for the degradation of GABA. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">By inhibiting this enzyme, Vigabatrin increases the levels of GABA, an inhibitory neurotransmitter in the brain, which helps to control seizures by reducing neuronal excitability.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Phenytoin</strong>: Incorrect. Phenytoin acts primarily by modulating sodium channels. It prolongs the inactivation state of Na+ channels, which helps to reduce neuronal firing and prevent seizure propagation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Lamotrigine</strong>: Also incorrect. Lamotrigine works by blocking voltage-sensitive sodium channels, which stabilizes neuronal membranes and inhibits the release of excitatory neurotransmitters that can trigger seizures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Valproate</strong>: This is incorrect as a response to this specific question. Although Valproate has multiple mechanisms, including the modulation of GABA pathways, it also affects sodium channels among its actions. However, its broader spectrum may make it a less specific answer compared to Vigabatrin in this context.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vigabatrin&#39;s primary mechanism of action is different from many other antiepileptic drugs in that it does not modulate sodium channels but instead increases GABA levels by inhibiting GABA-T. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This specific action is crucial for its effectiveness in treating epilepsy, particularly in resistant cases.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174349,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43673,
      "choices": [
        {
          "id": 174355,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Incision and drainage</span></span></span></p>"
        },
        {
          "id": 174356,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Sclerotherapy</span></span></span></p>"
        },
        {
          "id": 174357,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Radiotherapy</span></span></span></p>"
        },
        {
          "id": 174358,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Excision</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What should be the treatment for the pathology as shown in the given image.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-11-134436.JPG\" style=\"height:281px; width:300px\" /></span></span></p>",
      "unique_key": "Q4410327",
      "question_audio": null,
      "question_video": null,
      "map_id": 5576366,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT\" style=\"font-size:14.0pt\">Ans. D) Excision</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The appropriate treatment for the pathology depicted in the image, identified as an angular dermoid, is excision. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Angular dermoids are benign cystic lesions typically found in the lateral canthal region of the eye. Surgical excision is the preferred treatment to remove the cyst completely and prevent recurrence.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Incision and drainage:</span></strong><span style=\"font-size:14.0pt\"> Incision and drainage are not suitable for angular dermoids as they are cystic lesions requiring complete removal. Incision and drainage is performed for abscesses.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Sclerotherapy:</span></strong><span style=\"font-size:14.0pt\"> Sclerotherapy involves injecting a sclerosing agent into a cystic lesion to induce fibrosis and collapse. However, this technique is not commonly used for angular dermoids. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Radiotherapy:</span></strong><span style=\"font-size:14.0pt\"> Radiotherapy is not the primary treatment for angular dermoids. Surgical excision is preferred to remove the lesion completely and prevent recurrence.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Angular dermoids are benign cystic lesions commonly found in the lateral canthal region of the eye. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The treatment of choice for angular dermoids is surgical excision to remove the lesion completely and prevent recurrence. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Early intervention and complete excision are essential to prevent complications and achieve optimal cosmetic outcomes.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174358,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43675,
      "choices": [
        {
          "id": 174363,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Anti-Amphiphysin</span></span></span></p>"
        },
        {
          "id": 174364,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Anti-GAD</span></span></span></p>"
        },
        {
          "id": 174365,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Anti-Glycine receptor</span></span></span></p>"
        },
        {
          "id": 174366,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">None of the above</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old woman presents with severe muscle rigidity, painful spasms, and myoclonus. Her symptoms progressively worsened over several months, and she is now unable to walk due to stiffness. Imaging studies were unremarkable, but blood tests reveal specific antibodies. Which antibodies are most likely present in this patient&#39;s condition, which is consistent with progressive encephalomyelitis with rigidity and myoclonus (PERM)?</span></span><strong> </strong></p>",
      "unique_key": "Q9552446",
      "question_audio": null,
      "question_video": null,
      "map_id": 5576428,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C) Anti-Glycine receptor</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Anti-Glycine receptor antibodies are a key diagnostic marker for progressive encephalomyelitis with rigidity and myoclonus (PERM). These antibodies target glycine receptors, which are crucial for inhibitory neurotransmission. When disrupted, the lack of inhibitory signaling leads to severe muscle stiffness and spasms. Early recognition of this condition and detection of anti-GlyR antibodies allow for more targeted treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Anti-Amphiphysin:</span></strong><span style=\"font-size:14.0pt\"> These antibodies are associated with a paraneoplastic variant of stiff person syndrome but not directly linked to PERM.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Anti-GAD:</span></strong><span style=\"font-size:14.0pt\"> While these antibodies are found in stiff person syndrome, they are less specific to PERM.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. None of the above:</span></strong><span style=\"font-size:14.0pt\"> Incorrect, as anti-glycine receptor antibodies are associated with PERM.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Anti-glycine receptor antibodies are strongly associated with PERM and play a critical role in diagnosing this severe variant of stiff person syndrome.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174365,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43676,
      "choices": [
        {
          "id": 174367,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Metastatic Wilms tumor</span></span></span></p>"
        },
        {
          "id": 174368,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acute tubular necrosis</span></span></span></p>"
        },
        {
          "id": 174369,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Disseminated intravascular coagulation</span></span></span></p>"
        },
        {
          "id": 174370,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ruptured berry aneurysm </span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 61-year-old woman has experienced increasing malaise over the past five years. She has high blood pressure (150/95 mm Hg) but no other significant abnormalities on physical examination. One week later, she suddenly dies. The external and bisected appearances of both kidneys are shown in the images. What condition most likely caused her death?<strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-11-134513.JPG\" style=\"height:202px; width:300px\" /></p>",
      "unique_key": "Q6702049",
      "question_audio": null,
      "question_video": null,
      "map_id": 5576549,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Ruptured berry aneurysm</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The bisected kidney images suggest adult polycystic kidney disease, as seen by the large cysts replacing normal renal parenchyma. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This condition frequently leads to hypertension and renal dysfunction. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Additionally, patients with polycystic kidney disease are at increased risk of developing berry aneurysms in the cerebral arteries, which may rupture and cause sudden death.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Metastatic Wilms tumor:</span></strong><span style=\"font-size:14.0pt\"> Wilms tumor is a pediatric renal malignancy and rarely metastasizes to adults.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Acute tubular necrosis:</span></strong><span style=\"font-size:14.0pt\"> While this causes kidney injury, it does not result in cyst formation or sudden death.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Disseminated intravascular coagulation:</span></strong><span style=\"font-size:14.0pt\"> DIC results in widespread bleeding and clotting abnormalities but does not directly cause kidney cysts.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Adult polycystic kidney disease predisposes patients to cerebral berry aneurysms, which can rupture and cause sudden death.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174370,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43678,
      "choices": [
        {
          "id": 174375,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Requires aPTT monitoring in patients</span></span></p>"
        },
        {
          "id": 174376,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acts by activating antithrombin III</span></span></p>"
        },
        {
          "id": 174377,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Protamine sulfate antagonizes its action</span></span></p>"
        },
        {
          "id": 174378,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Has only in vivo anticoagulant action</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A physician is reviewing the properties and management protocols of anticoagulants in a medical seminar. Which of the following statements about heparin is NOT true?</span></span></p>",
      "unique_key": "Q7293330",
      "question_audio": null,
      "question_video": null,
      "map_id": 5576611,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Has only in vivo anticoagulant action</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The statement that heparin &quot;Has only in vivo anticoagulant action&quot; is not true. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Heparin functions as an anticoagulant both in vivo (within the body) and in vitro (outside the body, such as in laboratory tests or stored blood). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is often used in clinical settings to prevent clotting in samples or in devices like dialysis machines. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Heparin acts by enhancing the activity of antithrombin III, which inactivates enzymes in the clotting cascade, thus exerting its anticoagulant effects.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>A.</strong> <strong>Requires aPTT monitoring in patients</strong>: This statement is true. The activated partial thromboplastin time (aPTT) is commonly used to monitor the therapeutic levels of heparin when it is administered, especially when used for conditions requiring a precise adjustment of dosage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Acts by activating antithrombin III</strong>: This is also true. Heparin&#39;s primary mechanism of action involves accelerating the activity of antithrombin III, which helps inactivate thrombin and other clotting factors, thereby preventing the formation of fibrin clots.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C.</strong>&nbsp;<strong>Protamine sulfate antagonizes its action</strong>: True as well. Protamine sulfate is a medication that directly binds to heparin, neutralizing its anticoagulant effects. This is particularly useful in cases where there is a need to reverse heparin&#39;s effects rapidly, such as after surgery or in the event of an overdose.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Heparin functions as an anticoagulant both in vivo and in vitro, not exclusively in vivo. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This dual capability is vital for its use in various medical applications beyond direct patient care, including in laboratory settings and during procedures requiring extracorporeal circulation.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174378,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43680,
      "choices": [
        {
          "id": 174383,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Inguinal hernia</span></span></span></p>"
        },
        {
          "id": 174384,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Infertility</span></span></span></p>"
        },
        {
          "id": 174385,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Torsion</span></span></span></p>"
        },
        {
          "id": 174386,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Vaginal hydrocele</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A child is born with empty right-sided scrotum. Which of these is an unlikely problem the child may face in the future?</span></span></p>",
      "unique_key": "Q1532393",
      "question_audio": null,
      "question_video": null,
      "map_id": 5576633,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Vaginal hydrocele</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">An unlikely problem that a child born with an empty right-sided scrotum may face in the future is vaginal hydrocele. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vaginal hydrocele is the accumulation of fluid in the tunica vaginalis seen commonly in adults due to defective drainage of tunica vaginalis. It has no relation with undescended testis.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Inguinal hernia:</span></strong><span style=\"font-size:14.0pt\"> Boys with undescended testes may have an increased risk of inguinal hernia due to the persistence of the processus vaginalis. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Infertility:</span></strong><span style=\"font-size:14.0pt\"> Undescended testes are associated with an increased risk of infertility in adulthood due to impaired testicular development and function. This is a common concern for individuals with undescended testes. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Torsion:</span></strong><span style=\"font-size:14.0pt\"> Undescended testes are at a higher risk of testicular torsion, which is a medical emergency. The abnormal positioning of the testis predisposes it to torsion, which can compromise blood flow and lead to testicular damage if not promptly treated.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">While inguinal hernia, infertility, and torsion are common complications associated with undescended testes, vaginal hydrocele is less likely to occur in a child with an empty scrotum as it typically accompanies the descent of the testis into the scrotal sac. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174386,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43681,
      "choices": [
        {
          "id": 174387,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Infiltrating ductal carcinoma</span></span></span></p>"
        },
        {
          "id": 174388,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Phyllodes tumor</span></span></span></p>"
        },
        {
          "id": 174389,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Papillary carcinoma</span></span></span></p>"
        },
        {
          "id": 174390,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Medullary carcinoma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 41-year-old woman presents with a progressively enlarging mass in her left breast. On physical examination, the physician detects a 4 cm, firm, and discrete mass. A simple mastectomy and axillary lymph node sampling reveal a tan, soft mass with no lymph node metastases. Histologically, the tumor is composed of large cells with prominent nucleoli and vesicular nuclei, and it has a marked lymphocytic infiltrate. The tumor has a well-defined, non-infiltrative border, and the cells are negative for estrogen and progesterone receptors. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q9611441",
      "question_audio": null,
      "question_video": null,
      "map_id": 5576704,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Medullary carcinoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Medullary carcinoma of the breast is characterized by a well-circumscribed mass composed of large tumor cells with prominent nucleoli, vesicular nuclei, and abundant cytoplasm. It is often associated with a marked lymphocytic infiltrate and a discrete non-infiltrative border. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The tumor frequently lacks estrogen and progesterone receptors (hormone receptor-negative). Despite its aggressive histological appearance, it usually has a better prognosis than other triple-negative breast cancers.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-11-134546.JPG\" style=\"height:212px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Infiltrating lobular carcinoma:</span></strong><span style=\"font-size:14.0pt\"> This carcinoma type shows a distinctive single-file pattern of infiltration.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Phyllodes tumor:</span></strong><span style=\"font-size:14.0pt\"> A breast tumor characterized by a leaf-like pattern and rapid growth, often exhibiting benign or borderline behavior.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Papillary carcinoma:</span></strong><span style=\"font-size:14.0pt\"> Papillary carcinoma presents with papillary structures and often occurs in older women.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Medullary carcinoma of the breast is characterized by large tumor cells with prominent nucleoli, vesicular nuclei, and a marked lymphocytic infiltrate. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is typically hormone receptor-negative but has a relatively favorable prognosis.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174390,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43686,
      "choices": [
        {
          "id": 174407,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Dantrolene</span></span></span></p>"
        },
        {
          "id": 174408,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Succinylcholine</span></span></span></p>"
        },
        {
          "id": 174409,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vecuronium</span></span></span></p>"
        },
        {
          "id": 174410,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mivacurium</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During a pharmacology lecture on muscle relaxants, a professor discusses various drugs and their mechanisms of action related to muscle function. One of the drugs is known for not acting at the neuromuscular junction. Which of the following drugs fits this description?</span></span></p>",
      "unique_key": "Q3152562",
      "question_audio": null,
      "question_video": null,
      "map_id": 5577149,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">A) Dantrolene</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Dantrolene does not act on the neuromuscular junction; instead, it acts directly within muscle cells by inhibiting the release of calcium from the sarcoplasmic reticulum. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This unique mechanism of action makes it effective in the treatment of malignant hyperthermia, a life-threatening condition often triggered by certain anesthetic agents, and also for managing spasticity disorders. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">By reducing intracellular calcium concentrations, dantrolene helps to decrease muscle contractions.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>B.</strong> <strong>Succinylcholine</strong>: Incorrect as well. Succinylcholine is a depolarizing neuromuscular blocker that acts at the neuromuscular junction by mimicking acetylcholine as it binds to nicotinic receptors, causing an initial muscle contraction followed by paralysis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C.</strong> <strong>Vecuronium</strong>: Incorrect. Vecuronium is a non-depolarizing neuromuscular blocker that acts at the neuromuscular junction by competing with acetylcholine for binding to nicotinic receptors on the motor endplate, which prevents muscle contraction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Mivacurium</strong>: Also incorrect. Mivacurium is another neuromuscular blocker of the non-depolarizing type. It binds to the acetylcholine receptors at the neuromuscular junction, inhibiting the transmission of impulses and leading to muscle relaxation and paralysis during surgery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Dantrolene&#39;s mechanism of action is unique among drugs commonly used in anesthesia and muscle spasm management because it does not target the neuromuscular junction but rather acts directly within muscle cells to modulate calcium release, distinguishing it from other muscle relaxants.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174407,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43687,
      "choices": [
        {
          "id": 174411,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Subarachnoid hemorrhage</span></span></span></p>"
        },
        {
          "id": 174412,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Subdural hemorrhage </span></span></span></p>"
        },
        {
          "id": 174413,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Cerebral contusion</span></span></span></p>"
        },
        {
          "id": 174414,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Diffuse axonal injury</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old man is brought to emergency with loss of consciousness following RTA. GCS is 5/15 and the patient has decerebrate rigidity. CT brain was performed and the image is given below. Which of the following is the most likely diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-11-134614.JPG\" style=\"height:291px; width:300px\" /></span></span></p>",
      "unique_key": "Q5531567",
      "question_audio": null,
      "question_video": null,
      "map_id": 5577210,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Diffuse axonal injury </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The most likely diagnosis based on the clinical presentation, decerebrate rigidity, and a normal CT brain finding is diffuse axonal injury (DAI). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Diffuse axonal injury is a severe form of traumatic brain injury characterized by widespread damage to the axons in the brain due to rotational acceleration-deceleration forces commonly seen in high-impact accidents such as road traffic accidents (RTA).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The CT brain image appears normal, which is typical in cases of diffuse axonal injury, as the injury occurs at a microscopic level and may not be visible on conventional imaging. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Patients with diffuse axonal injury often present with altered level of consciousness, decerebrate or decorticate posturing, and neurological deficits.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Subarachnoid hemorrhage:</span></strong><span style=\"font-size:14.0pt\"> Subarachnoid hemorrhage typically presents with acute severe headache, often described as the worst headache of the patient&#39;s life, and may be associated with meningeal signs such as neck stiffness. CT brain imaging would typically reveal hyper-density in the subarachnoid space. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Subdural hemorrhage:</span></strong><span style=\"font-size:14.0pt\"> Subdural hemorrhage presents with symptoms of increased intracranial pressure such as headache, altered level of consciousness, and focal neurological deficits, and may manifest as a crescent-shaped hyperdensity on CT brain imaging. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Cerebral contusion:</span></strong><span style=\"font-size:14.0pt\"> Cerebral contusion refers to bruising of the brain tissue and typically presents with focal neurological deficits corresponding to the area of contusion. CT brain imaging may reveal areas of hyperdensity or hypodensity depending on the stage of the contusion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Diffuse axonal injury is a severe form of traumatic brain injury characterized by widespread axonal damage due to rotational forces. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Diagnosis may be challenging on CT imaging, but it should be suspected in patients with high-impact trauma, altered level of consciousness, and decerebrate or decorticate posturing. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">MRI is more sensitive for detecting diffuse axonal injury, especially in cases where CT findings are normal.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174414,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43689,
      "choices": [
        {
          "id": 174419,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Kidney function test</span></span></span></p>"
        },
        {
          "id": 174420,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Audiometry</span></span></span></p>"
        },
        {
          "id": 174421,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Liver function tests</span></span></span></p>"
        },
        {
          "id": 174422,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Platelet count</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient is receiving linezolid treatment for an extended period due to a complicated infection. What should be monitored if linezolid is administered for more than 14 days to ensure patient safety and manage potential side effects?<strong> </strong></span></span></p>",
      "unique_key": "Q1316315",
      "question_audio": null,
      "question_video": null,
      "map_id": 5577312,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Platelet count</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Linezolid, an oxazolidinone antibiotic, is used for treating infections caused by Gram-positive bacteria, including those resistant to other antibiotics. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A significant potential side effect of linezolid, especially when used for periods longer than 14 days, is thrombocytopenia. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This condition involves a decrease in platelets, which are critical for proper blood clotting. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Monitoring the platelet count is essential to detect this potentially serious side effect early and adjust treatment as necessary to prevent complications such as excessive bleeding.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A.&nbsp;</span></strong><span style=\"font-size:14.0pt\"><strong>Kidney function test</strong>: While monitoring kidney function is important for many drugs, linezolid is not specifically known for causing nephrotoxicity, making this less relevant compared to platelet monitoring.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Audiometry</strong>: Monitoring hearing, or audiometry, is generally not required with linezolid. Audiometry is more relevant for drugs known to cause ototoxicity, such as certain aminoglycoside antibiotics.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Liver function tests</span></strong><span style=\"font-size:14.0pt\">: Although monitoring liver function is critical for drugs metabolized through the liver and those known for causing hepatotoxicity, linezolid is not specifically associated with liver damage, making platelet count monitoring more pertinent in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Monitoring platelet count is crucial when administering linezolid for more than 14 days due to the risk of thrombocytopenia. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This monitoring helps ensure early detection and management of this potential side effect, maintaining patient safety during prolonged treatment.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 174422,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43690,
      "choices": [
        {
          "id": 174423,
          "text": "<p><span style=\"font-size:14.0pt;\">Colon</span></p>"
        },
        {
          "id": 174424,
          "text": "<p><span style=\"font-size:14.0pt;\">Breast</span></p>"
        },
        {
          "id": 174425,
          "text": "<p><span style=\"font-size:14.0pt;\">Prostate</span></p>"
        },
        {
          "id": 174426,
          "text": "<p><span style=\"font-size:14.0pt;\">Melanoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old man presents to the clinic with a history of intermittent abdominal pain and unintentional weight loss over the past few months. Upon further evaluation, he is found to have multiple enhancing liver masses on imaging studies. Which of the following given cancers is least likely to metastasize to the liver?</span></p>",
      "unique_key": "Q5583040",
      "question_audio": null,
      "question_video": null,
      "map_id": 5577313,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Prostate</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Prostate cancer tends to metastasize to bones rather than the liver. Bone metastases are a hallmark of advanced prostate cancer. Liver metastases from prostate cancer are relatively rare compared to bone metastases.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;A. Colon:&nbsp;</strong>Colon cancer commonly metastasizes to the liver. The liver is one of the most common sites of metastasis for colon cancer, and it frequently spreads to the liver through the portal vein.</span></p><p>&nbsp;</p><p><span style=\"font-size:14pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:14.0pt;\"><strong>B. Breast:&nbsp;</strong>Breast cancer can metastasize to various organs, including the liver. Liver metastases in breast cancer are not uncommon, and the liver is considered a potential site of spread for breast cancer cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:14pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:14.0pt;\"><strong>D.&nbsp;Melanoma</strong>: Melanoma is known for its propensity to metastasize to various organs, including the liver. Liver metastases are common in advanced melanoma cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Prostate Cancers rarely metastasize to the liver.</span></li></ul>",
      "correct_choice_id": 174425,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43692,
      "choices": [
        {
          "id": 174431,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lactose fermenters (LF)</span></span></p>"
        },
        {
          "id": 174432,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nonlactose fermenters (NLF)</span></span></p>"
        },
        {
          "id": 174433,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Late lactose fermenters (LLF)</span></span></span></p>"
        },
        {
          "id": 174434,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">None of the above</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A microbiology technician is performing routine stool cultures on MacConkey agar to identify and classify bacteria from the family Enterobacteriaceae based on their lactose fermentation properties. A sample yields colonies that initially appear colorless at 24 hours but turn pink after 48 hours of incubation. Based on this information, which group of Enterobacteriaceae does the organism likely belong to? </span></span></p>",
      "unique_key": "Q4332416",
      "question_audio": null,
      "question_video": null,
      "map_id": 5577405,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Late lactose fermenters (LLF)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Late lactose fermenters, also previously known as paracolon bacilli, ferment lactose slowly, typically taking 2 to 8 days to show a positive reaction. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">On MacConkey agar, these organisms initially produce pale or colorless colonies within the first 24 hours of incubation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">By the second day or later, the colonies turn pink, indicating delayed lactose fermentation. This is characteristic of the late lactose fermenters group.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Lactose fermenters (LF):</span></strong><span style=\"font-size:14.0pt\"> Rapidly ferment lactose and produce pink-colored colonies on MacConkey agar within 24 hours.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Nonlactose fermenters (NLF):</span></strong><span style=\"font-size:14.0pt\"> do not ferment lactose and consistently produce pale or colorless colonies, even after extended incubation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. None of the above:&nbsp;</span></strong><span style=\"font-size:14.0pt\">This is incorrect as the correct answer is available in the provided options.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-11-153409.JPG\" style=\"height:574px; width:933px\" /></span></strong></span></span></p>",
      "correct_choice_id": 174433,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}